The effect of the serotherapy regimen used and the marrow cell dose received on rejection, graft-versus-host disease and outcome following unrelated donor bone marrow transplantati... by Byrne, J, Stainer, C, Cull, G, Haynes, A, Bessell, E, Hale, G, Waldmann, H, Russell, N

Intermittent versus continuous oxaliplatin and fluoropyrimidine combination chemotherapy for first-line treatment of advanced colorectal cancer: results of the randomised phase 3 M... by Adams, R, Meade, A, Seymour, M, Wilson, R, Madi, A, Fisher, D, Kenny, S, Kay, E, Hodgkinson, E, Pope, M, Rogers, P, Wasan, H, Falk, S, Gollins, S, Hickish, T, Bessell, E, Propper, D, Kennedy, M, Kaplan, R, Maughan, T

Interim results of a UK NCRI randomised trial comparing involved field radiotherapy with no further treatment after 3 cycles ABVD and a negative PET scan in clinical stages IA/IIA... by Radford, J, Barrington, S, O'Doherty, M, Qian, W, Mouncey, P, Pettengell, R, Hoskin, P, Bessell, E, Coltart, R, Cunningham, D, Culligan, D, Hatton, C, Johnson, P, Kruger, A, Linch, D, Lister, T, Marcus, R, Sadullah, S, Wimperis, J, Hancock, B, Illidge, T, Collaborators, PET